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A B S T R A C T   
American trypanosomiasis is a parasitic neglected disease, responsible for the death of approximately 10,000 
people every year. Amphibians are recognized for producing in their cutaneous glands substances with phar-
macological potential against a variety of pathologies. Here we investigated the antiprotozoal activity against 
Trypanosoma cruzi of bufadienolides isolated from the parotoid glands secretions of the toad Rhinella centralis 
from Panama. NMR and mass spectrometry analysis led to the identification of the active compound 19-hydroxy- 
bufalin, for which its antitrypanosomal activity and occurrence in the genus Rhinella are reported for the first 
time. This compound showed low cytotoxicity and significant selectivity which confers to it a potential role for 
the treatment of Chagas disease.   
American trypanosomiasis, also known as Chagas disease, is a zoo-
notic disease caused by the protozoan parasite Trypanosoma cruzi. Each 
year more than 10,000 people worldwide die of Chagas disease-related 
causes, and 8 million people are estimated to be infected by T. cruzi in 
Latin America (WHO, 2019). Currently, benznidazole and nifurtimox 
are the drugs available for the treatment of Chagas disease; however, 
these medications lead to the development of severe secondary effects 
and are effective only during the first weeks after infection (Castro et al., 
2006). 
Amphibians of the genus Rhinella contains in their skin secretions 
metabolites of the bufadienolides family, which are polyhydroxy ste-
roids containing a 2-pyrone ring at position 17 of the steroidal core. 
These compounds are of interest due to their high chemical diversity and 
promising pharmacological activities against bacteria, fungi and trypa-
nosomatid parasites (Barnhart et al., 2017; Cunha Filho et al., 2005; 
Tempone et al., 2008). The endemic Panamanian toad Rhinella centralis 
(Narvaes and Rodrigues, 2009), formerly known as Bufo granulosus, 
inhabits the lowlands of the Pacific slope of Panama from Chiriquí to 
Darien provinces (Frost, 2019; IUCN, 2019). This relatively small species 
of toad is nocturnal and terrestrial, and breeds throughout the wet 
season particularly on rainy nights (Roberto Iba~nez et al., 1999). In this 
communication, we are reporting for the first time the occurrence in the 
genus Rhinella and the antitrypanosomal activity of 19-hydroxy-bufalin, 
a bufadienolide isolated from the parotoid gland secretions of the toad 
R. centralis. 
Adult specimens of R. centralis were collected in Pacora, Panama 
Province (Fig. 1-A) (collection permit SE/A-32-15). Parotoid glands 
secretion was obtained by electrical stimulation, after applying 5 V at 60 
Hz for 30 s on the toads’ dorsal region, using a homemade trans-
cutaneous amphibian stimulator (Grant and Land, 2002). The secretions 
were placed in vials containing MeOH and stored at   20 C until 
analysis. The methanolic soluble extract was loaded in Supelclean LC-18 
solid phase extraction (SPE) cartridges (Supelco, Bellefonte, PA, USA), 
and fractionated using vacuum employing a three-step gradient 
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composed of mixtures of 40, 80 and 100% of methanol in water at 10 
mL min  1. Methanol was removed by rotary evaporation under reduced 
pressure and the remaining water lyophilized obtaining three fractions 
F1–F3. The three fractions were evaluated against trypomastigotes of 
T. cruzi. Active fraction F2 was diluted in MeOH at 30 mg mL  1 and 
subjected to reversed-phase high performance liquid chromatography 
(RP-HPLC) employing a semi-preparative Polar C18 column (250  10 
mm, 4 μm, 80 Å) (Phenomenex®, Torrance, CA, USA). Injections of 100 
μL were carried out and elution was set at a flow rate of 3 mL min  1. The 
solvent system consisted of water with 0.1% of trifluoroacetic acid (TFA) 
(Solvent A), and a 1/1 mixture of MeOH/CH3CN acidified with TFA at 
0.1% (Solvent B). Elution was carried out using a gradient from 20% to 
100% of solvent B in solvent A in 60 min. 
Structural elucidation was carried out by spectroscopic and spec-
trometric means. Nuclear magnetic resonance (NMR) experiments were 
carried out at 25 C on an Eclipse 400 Fourier transform spectrometer 
(JEOL, Peabody, MA, USA). For NMR analysis, the samples were dis-
solved in deuterated methanol, and the spectra referenced based on the 
non-deuterated methanol residual signal (3.31 for δH and 49.0 for δC). 
High resolution mass spectrometry analysis was carried out on an 
UltrafleXtreme MALDI-TOF/TOF (Bruker Daltonics, Billerica, MA, 
USA). For MALDI-TOF-TOF analysis, 2 μL of the sample (19-hydroxy- 
bufalin) dissolved in methanol, were transferred to a MTP plate (Bruker 
Daltonics, Billerica, MA, USA), and mixed with 1 μL of the matrix 
(α-cyano-4-hydroxy-cinammic acid, Sigma Aldrich). All experiments 
were carried out in reflectron positive mode. Peptide calibration stan-
dard II (Bruker, Daltonics, MA) was used as external calibrant. 
Antitrypanosomal bioassay was carried out on recombinant Tula-
huen clone C4 of T. cruzi trypomastigotes (American Type Culture 
Collection, ATCC), Manassas, VA, USA), which expresses the 
β-galactosidase enzyme that serves as a reporter of viability (Buckner 
et al., 1996). Transfected parasites were maintained at 37 C under a 5% 
CO2 atmosphere in RPMI-1640 culture medium with L-glutamine, 
4-(2-Hydroxyethyl)-piperazine-1-ethanesulfonic acid buffer, NaHCO3, 
10% FBS and 1% penicillin/streptomycin as supplements. 
Vero cells (ATCC) were grown for 24 h, and one day prior to the 
experiment the cells were infected with trypomastigotes. Samples were 
dissolved in DMSO and added to the medium at 10.0, 2.0, 0.4 and 0.1 
μg/mL and incubated for five days. To determine the antitrypanosomal 
activity, chlorophenol-red-β-D-galactopyranoside (Roche Applied Sci-
ence) was added to each well and allowed to react with the β-galacto-
sidase of the remnant living parasites for 4.5 h. Benznidazole was used as 
positive control (IC50  0.75 μg/mL). Absorbance was measured at 570 
nm using a color plate reader (Sinergy HT, BioTek Instruments Inc, 
Winooski, VT, USA). 
For cytotoxicity assays, Vero cells were cultivated in 96-well plates at 
37 C under a 5% CO2 atmosphere, using RPMI-1640 medium (Sigma- 
Aldrich, USA) sterilized with 1% penicillin/streptomycin and supple-
mented with 10% FBS (fetal bovine serum; Gibco, Invitrogen, Carlsbad, 
CA, USA). The cells were allowed to adhere for 24 h prior to incubation 
for five days with the samples. During the treatment, DMSO was used as 
negative control, and samples were assayed at the same concentrations 
used in the anti-trypanosomal assay. After incubation, MTT (3-(4, 5-di- 
methyl-thiazol-2-yl)-2, 5-di-phenyl-tetra-zolium bromide) was added to 
each well and absorbance was determined 4 h later at 570 nm, using a 
color plate reader. Cytotoxicity was evaluated colorimetrically by 
calculating the ability of the remnant living Vero cells to reduce the pale 
yellow MTT into the black purple formazan product, as described earlier 
(Mosmann, 1983). All bioassays were performed in duplicate and the 
IC50 values were determined employing the Data Analysis complement 
Fig. 1. (A) Distribution range, collection site and adult of Rhinella centralis. Its distribution was partly based on IUCN. (2019). (B) RP-HPLC Chromatogram profile of 
the fraction F2 obtained by VLC (80% MeOH in H2O) from parotoid glands secretion of R. centralis. Black arrow indicates 19-hydroxy-bufalin (1). (C) Key COSY and 
HMBC correlations of 19-hydroxy-bufalin (1). (D) Effect of 19-hydroxy-bufalin (1) against trypomastigotes of T. cruzi. 
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Wizard of Excel (2000) (Microsoft, Seatle, WA, USA). 
The skin secretion of R. centralis (1093 mg) subjected to SPE frac-
tionation resulted in three fractions F1–F3. Antitrypanosomal activity 
was found in fraction F2 (320 mg) which was subjected to semi- 
preparative RP-HPLC purification leading to the isolation of com-
pound 1 (17.6 mg), eluted at 27.7 min, active against T. cruzi trypo-
mastigotes (Fig. 1-B). The structural elucidation of compound 1 was 
carried out by spectroscopic analyses and comparison with data from the 
literature (Verpoorte and Svendsen, 1979). 
The molecular formula of compound 1 was determined as C24H34O5 
based on HR-MALDI-TOF-TOF MS data which showed a sodiated adduct 
of the molecular ion at m/z 425.2295 [M  Na](calcd for C24H34O5Na, 
425.2298). Eight degrees of unsaturation were calculated from the 
molecular formula: three accounted for a carbonyl and two double 
bonds, hence compound 1 possess five rings. 
In general, analysis of the 1H and 13C NMR data (Table 1) revealed 
the typical spectroscopic features of a bufadienolide including reso-
nances for the 2-pyrone ring at δC 125.1 (C-20), 150.5 (C-21), 149.5 (C- 
22), 115.56 (C-23) and 164.9 (C-24), (Verpoorte et al., 1980). 1H NMR 
showed signals for two diastereotopic protons mutually coupled, 
consistent with an oxomethylene at δH 3.83 (d, J  11.2 Hz) and 3.41 (d, 
J  11.2 Hz), attached to carbon C-19 (δC 66.17) using HSQC data. The 
steroidal nucleus was assembled using COSY and J2,3 HMBC correlations 
(Fig. 1-C) being consistent with the structure of 19-hydroxy-bufalin (1). 
19-hydroxy-bufalin (1) has been isolated from toads of the genera 
Bufo, Bufotes and Duttaphrynus, although not known in the genus 
Rhinella (Gao et al., 2010; Gella et al., 1995; Verpoorte et al., 1980). In 
our study, 19-hydroxy-bufalin (1) led to a growth inhibition in a 
dose-dependent manner with an IC50 of 7.81 μg/mL (Fig. 1-D) when 
assayed against T. cruzi trypomastigotes. Moreover, the cytotoxicity 
evaluation on epithelial kidney Vero cells exhibited a low inhibitory 
concentration with an IC50 of 71.58 μg/mL, resulting in a significant 
selectivity index (SI  IC50 Vero cells/IC50 T. cruzi) of 9.16. The selec-
tivity index is a good reference of the pharmacological activity and 
safety of a drug. For instance, the higher the SI, the more effective and 
safe would be a compound during in vivo antiprotozoal treatment 
(Nogueira et al., 2009). 
Only one bufadienolide, hellebrigenin, isolated from the parotoid 
macroglands of Rhinella jimi, has shown activity against T. cruzi, with a 
reported IC50 of 91.75 μg/mL (Tempone et al., 2008). To the best of our 
knowledge, in this study we report for the first time the anti-
trypanosomal activity of 19-hydroxy-bufalin and its occurrence in the 
genus Rhinella. The therapeutic window of 19-hydroxy-bufalin against 
American trypanosomiasis points out the need for research on the 
mechanism by which this natural product acts. This communication 
highlights the importance of amphibians as a source for the discovery of 
natural products with potential for the treatment of neglected human 
diseases. 
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Table 1 
1H and 13C NMR data (400 MHz) of 19-hydroxy-bufalin (1) in CD3OD, chemical 
shifts (δ) in ppm.  
No. δC, typea δH, mult.b,c,d (J in Hz) 
1 24.3, CH2 1.88, m 
1.39, m 
2 33.1, CH2 2.13, m 
1.72, m 
3 67.6, CH 4.04, m 
4 28.4, CH2 1.58, m 
n.d. 
5 29.8, CH 2.21, m 
6 27.6, CH2 1.88, m 
1.22, m 
7 22.8, CH2 1.49, m 
1.22, m 
8 43.0, CH 1.68, m 
9 36.6, CH 1.80, m 
10 40.6, C  
11 22.3, CH2 1.80, m 
1.35, m 
12 42.4, CH2 1.49, m 
1.39, m 
13 49.9, C  
14 86.4, C  
15 34.2, CH2 1.85, m 
1.39, m 
16 29.9, CH2 2.13, m 
1.72, m 
17 52.4, CH 2.54, m 
18 17.4, CH3 0.70, s 
19 66.1, CH2 3.83, d (11.24) 
3.41, d (11.24) 
20 125.1, C  
21 150.5, CH 7.42, m 
22 149.5, CH 7.98, dd (2.44, 9.28) 
23 115.5, CH 6.27, d (9.76) 
24 164.9, C   
a Type of carbon was determined by DEPT spectra (90 and 135). 
b Assignments were made by analysis of COSY, HSQC and HMBC spectra. 
c Multiplets are identified as s (singlet), d (doublet), dd (doublet of doublets) 
or m (when multiplicity is not clear). 
d Overlapped signals are reported without multiplicity. n.d.  not detected. 
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